Next earnings date: 5 Aug 2025

Microbix Biosystems Inc. – TSX:MBX.TO
Microbix Biosystems stock price today
Microbix Biosystems stock price monthly change
Microbix Biosystems stock price quarterly change
Microbix Biosystems stock price yearly change
Microbix Biosystems key metrics
Market Cap | 53.81M |
Enterprise value | 49.02M |
P/E | -141.77 |
EV/Sales | 2.93 |
EV/EBITDA | 33.95 |
Price/Sales | 3.31 |
Price/Book | 2.36 |
PEG ratio | 3.30 |
EPS | 0.01 |
Revenue | 19.64M |
EBITDA | 3.68M |
Income | 1.43M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -2.34% |
Oper. margin | 1.71% |
Gross margin | 54.35% |
EBIT margin | 1.71% |
EBITDA margin | 18.75% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMicrobix Biosystems stock price history
Microbix Biosystems stock forecast
Microbix Biosystems financial statements
Mar 2023 | 4.21M | -169.75K | -4.02% |
---|---|---|---|
Jun 2023 | 5.53M | -769.10K | -13.91% |
Sep 2023 | 4.26M | 1.99M | 46.84% |
Mar 2024 | 5.63M | 377.73K | 6.71% |
2025 | 29.12M | 2.75M | 9.47% |
---|---|---|---|
2026 | 39.23M | 6.89M | 17.57% |
Analysts Price target
Financials & Ratios estimates
Mar 2023 | 33194482 | 9.82M | 29.61% |
---|---|---|---|
Jun 2023 | 34295095 | 11.65M | 33.98% |
Sep 2023 | 35653024 | 11.02M | 30.93% |
Mar 2024 | 37922214 | 10.16M | 26.81% |
Mar 2023 | -1.05M | -551.11K | 903.25K |
---|---|---|---|
Jun 2023 | 2.13M | -215.11K | -228.69K |
Sep 2023 | -1.45M | -117.85K | -228.62K |
Mar 2024 | 839.24K | -637.90K | -111.10K |
Microbix Biosystems alternative data
Aug 2023 | 100 |
---|---|
Sep 2023 | 100 |
Oct 2023 | 100 |
Nov 2023 | 100 |
Dec 2023 | 100 |
Jan 2024 | 100 |
Feb 2024 | 100 |
Mar 2024 | 100 |
Apr 2024 | 100 |
May 2024 | 100 |
Jun 2024 | 100 |
Jul 2024 | 100 |
Microbix Biosystems other data
-
What's the price of Microbix Biosystems stock today?
One share of Microbix Biosystems stock can currently be purchased for approximately $0.83.
-
When is Microbix Biosystems's next earnings date?
Microbix Biosystems Inc. is estimated to report earnings on Tuesday, 5 Aug 2025.
-
Does Microbix Biosystems pay dividends?
No, Microbix Biosystems does not pay dividends.
-
How much money does Microbix Biosystems make?
Microbix Biosystems has a market capitalization of 53.81M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 53.77% to 25.39M US dollars.
-
What is Microbix Biosystems's stock symbol?
Microbix Biosystems Inc. is traded on the TSX under the ticker symbol "MBX.TO".
-
What is Microbix Biosystems's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Microbix Biosystems?
Shares of Microbix Biosystems can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Microbix Biosystems have?
As Jul 2024, Microbix Biosystems employs 100 workers.
-
When Microbix Biosystems went public?
Microbix Biosystems Inc. is publicly traded company for more then 29 years since IPO on 13 Aug 1996.
-
What is Microbix Biosystems's official website?
The official website for Microbix Biosystems is microbix.com.
-
Where are Microbix Biosystems's headquarters?
Microbix Biosystems is headquartered at 265 Watline Avenue, Mississauga, ON.
-
How can i contact Microbix Biosystems?
Microbix Biosystems's mailing address is 265 Watline Avenue, Mississauga, ON and company can be reached via phone at +90 53618910.
Microbix Biosystems company profile:

Microbix Biosystems Inc.
microbix.comTSX
100
Biotechnology
Healthcare
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Mississauga, ON L4Z 1P3
:
ISIN: CA59501P1045
CUSIP: 59501P104